期刊文献+

HO-1基因启动子区多态性与客家人群糖尿病个体冠心病患病风险关联 被引量:1

A polymorphism in HO-1 gene promoter increases risk for coronary artery disease and KeJia population
原文传递
导出
摘要 目的:通过检测客家人群冠心病患者HO-1基因启动子区GT重复多态性,旨在阐明HO-1基因多态性与冠心病易感性的关联。方法:选择广东梅州客家地区确诊的冠心病患者100例为病例组,经冠状动脉造影或无创检查排除冠心病的个体100例为对照组。采用荧光标记PCR和毛细管电泳相结合技术检测HO-1启动子区(GT)n多态性并进行基因分型,结合冠心病危险因素,比较携带不同等位基因/基因型的患者冠心病的患病风险。结果:(GT)n重复次数在16~39之间,将(GT)n重复系列分为L(n〉30)和S(n≤29)2种等位基因,S/S、S/L、L/L3种基因型。病例组与对照组个体基因型分布差异无统计学意义(校正后OR=1.13,95%CI=0.95~1.24),但分层分析后发现携带L等位基因(S/L+L/L基因型)的糖尿病个体冠心病的发病风险增加更显著(校正后OR=2.29,95%CI=1.06~4.80)。结论:HO-1基因多态性与客家人群冠心病易感性相关,能明显增加糖尿病个体冠心病患病风险。 Objective:This study is designed to investigate the relationship between short tandem repeat(STR) polymorphism in Heme oxygenase-1(HO-1) gene promoter and susceptibility of CAD in Ke-jia population,contributes to provide a new strategy for prevention and treatment of CAD by using HO-1 for this population.Method:A total of 100 patients who were diagnosed as having CADs were selected in this study,another 100 subjects who were without evidence of CADs with their sex and age similar to CAD patients were selected as controls.Genotyping was performed using polymerase chain reaction followed by capillary electrophoresis automated DNA sequencer.Each size of the(GT)n repeat was calculated using the Gene Mapper Analysis software.Result:A(GT)n polymorphism was found in the HO-1 gene promoter with n=16-39.According to reference,the alleles were then classified into two subgroups: 'S' allele(n29) and 'L' allele(n29),the subjects were then classified as having an S/S,S/L,or L/L genotypes.Distributions of genotypes were similar between cases and controls,but not after stratified analysis,L allele(L/L+L/S genotypes) is susceptive to CAD in patients with diabetes(adjusted OR=2.29,95%CI=1.06-4.80).Conclusion:The(GT)n polymorphism in HO-1 gene promoter is related to susceptibility to CAD in patients with diabetes.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第2期147-151,共5页 Journal of Clinical Cardiology
基金 广东省梅州市科委基金资助项目(No:2008B43)
关键词 冠状动脉疾病 血红素氧化酶-1 基因多态性 糖尿病 coronary artery disease heme oxygenase-1 gene polymorphism diabetes
  • 相关文献

参考文献12

  • 1韦叶生,蓝艳,刘运广,唐任光,蓝景生.白细胞介素-6基因多态性与冠心病的相关性研究及其对血脂的影响[J].中国危重病急救医学,2006,18(4):233-236. 被引量:18
  • 2高波,李忠诚.基质金属蛋白酶-3血浆水平及其启动子基因5A/6A多态性与冠心病关系的研究[J].中国危重病急救医学,2004,16(9):536-539. 被引量:19
  • 3BACH F H.Heme oxygenase-1 as a protective gene[J].Wien Klin Wochenschr,2002,114(Suppl 4):1-3.
  • 4CHEN S M,LI Y G,WANG D M.Study on changes of haem oxygenase-1 expression and in patients with coronary heart disease[J].Clin Cardiol,2005,28:197-201.
  • 5SCHILLINGER M,EXNER M,MLEKUSCH W,et al.Heme oxygenase-1 genotype is a vascular anti-inflammatory factor following balloon angioplasty[J].J Endovasc Ther,2002,9:385-394.
  • 6ONO K,GOTO Y,TAKAGI S,et al.A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese[J].Atherosclerosis,2004,173:315-319.
  • 7ONO K,MANNAMI T,IWAI N.Association of a promoter variant of the haeme oxygenase-1 gene with hypertension in women[J].J Hypertens,2003,21:1497-1503.
  • 8EXNER M,MINAR E,WAGNER O,et al.The role of heme oxygenase-1 promoter polymorphisms in human disease[J].Free Radic Biol Med,2004,37:1097-1104.
  • 9FUNK M,ENDLER G,SCHILLINGER M,et al.The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events:the influence of other vascular risk factors[J].Thromb Res,2004,113:217-223.
  • 10KANEDA H,OHNO M,TAGUCHI J,et al.Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors[J].Arterioscler Thromb Vasc Biol,2002,22:1680-1685.

二级参考文献22

  • 1高波,李忠诚.基质金属蛋白酶-3血浆水平及其启动子基因5A/6A多态性与冠心病关系的研究[J].中国危重病急救医学,2004,16(9):536-539. 被引量:19
  • 2韦叶生,蓝艳,尤燕舞,唐任光,黄燕,张梁,罗斌.转化生长因子-β_1的基因型及血清水平与2型糖尿病肾病的相关性研究[J].中华检验医学杂志,2005,28(2):173-177. 被引量:10
  • 3Zhang Y,Hayes A,Pritchard A,et al.Interleukin-6 promoter polymorphism:risk and pathology of Alzheimer′s disease[J].Neurosci Lett,2004,362:99-102.
  • 4Nishimura M,Matsuoka M,Maeda M,et al.Association between interleukin6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy[J].Hum Immunol,2002,63:696-700.
  • 5Ota N,Nakajima T,Nakazawa I,et al.A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density[J].J Hum Genet,2001,46:267-272.
  • 6Georges J L,Loukaci V,Poirier O,et al.Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction:the ECTIM study.Etude Cas-Temoin de L′Infarctus du Myocarde[J].J Mol Med,2001,79:300-305.
  • 7Brull D J,Montgomery H E,Sanders J,et al.Interleukin-6 gene 174g》c and -572g》c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery[J].Arterioscler Thromb Vasc Biol,2001,21:1458-1463.
  • 8Kitamura A,Hasegawa G,Obayashi H,et al.Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes[J].Diabet Med,2002,19:1000-1005.
  • 9Libby P,Ridker P M,Maseri A.Inflammation and atherosclerosis[J].Circulation,2002,105:1135-1143.
  • 10Ikeda U,Ito T,Shimada K,et al.Interleukin-6 and acute coronary syndrome[J].Clin Cardiol,2001,24:701-704.

共引文献35

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部